MannKind Corporation - 54 Year Dividend History | MNKD
Historical dividend payout and yield for MannKind Corporation (MNKD) since 1971. The current TTM dividend payout for MannKind Corporation (MNKD) as of February 21, 2025 is $0.00. The current dividend yield for MannKind Corporation as of February 21, 2025 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$1.588B |
$0.199B |
|
Mannkind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Company's lead product, the Technosphere Insulin System, consists of the Company's dry-powder Technosphere formulation of insulin and the Company's MedTone inhaler through which the powder is inhaled into the deep lung.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
